NCT06018025View on ClinicalTrials.gov

NDPH Biomarker Study in Children and Adolescents

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
New Persistent Daily Headache
Interventions
DRUG

CGRP antibody

treatment with CGRP antibody for 4 months

Trial Locations (1)

27710

RECRUITING

Duke University Health System, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

International Headache Society

UNKNOWN

lead

Duke University

OTHER

NCT06018025 - NDPH Biomarker Study in Children and Adolescents | Biotech Hunter | Biotech Hunter